Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
S19 IPV
- Development stage
- Preclinical
- Lead developer
- Biological E
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Subcutaneous
01
Overview
S19 IPV is an inactivated poliovirus vaccine (IPV) being developed by Bharat Biotech for the prevention of poliomyelitis. The vaccine is formulated using the S19 virus strain, which is a hyper-attenuated, genetically stabilized derivative of the Sabin strain. The S19 strain is designed to be highly restricted in its ability to replicate at human body temperature and has a significantly reduced risk of reverting to a neurovirulent form during manufacturing. This allows the vaccine to be produced under lower biosafety containment levels (such as BSL-2) compared to conventional IPVs that require high-containment facilities. S19 IPV is currently in preclinical development.
- Other names
- S19 inactivated poliovirus vaccineS-19 inactivated poliovirus vaccineS 19 inactivated poliovirus vaccineSabine S19 IPV
02
Targets
Poliovirus capsid proteins
Beyond the preview
Go deeper on S19 IPV.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on S19 IPV.